Krishna Institute of Medical Sciences Ltd
NSE:KIMS

Watchlist Manager
Krishna Institute of Medical Sciences Ltd Logo
Krishna Institute of Medical Sciences Ltd
NSE:KIMS
Watchlist
Price: 600.75 INR 0.31%
Market Cap: 240.4B INR
Have any thoughts about
Krishna Institute of Medical Sciences Ltd?
Write Note

Net Margin
Krishna Institute of Medical Sciences Ltd

12.3%
Current
16%
Average
2.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
12.3%
=
Net Income
3.3B
/
Revenue
27.1B

Net Margin Across Competitors

Country IN
Market Cap 239.6B INR
Net Margin
12%
Country US
Market Cap 78.6B USD
Net Margin
9%
Country SA
Market Cap 98B SAR
Net Margin
21%
Country ZA
Market Cap 24.1B Zac
Net Margin
19%
Country ZA
Market Cap 20B Zac
Net Margin
6%
Country CN
Market Cap 129.6B CNY
Net Margin
18%
Country MY
Market Cap 62.8B MYR
Net Margin
11%
Country IN
Market Cap 1.1T INR
Net Margin
19%
Country US
Market Cap 12.3B USD
Net Margin
15%
Country IN
Market Cap 1T INR
Net Margin
5%
Country US
Market Cap 12B USD
Net Margin
7%
No Stocks Found

Krishna Institute of Medical Sciences Ltd
Glance View

Market Cap
240.4B INR
Industry
Health Care

Krishna Institute of Medical Sciences Ltd. (KIMS) has steadily carved out a significant presence in the Indian healthcare sector, rooted in the ethos of delivering accessible and high-quality care. Emerging from its base in Hyderabad, the institution has expanded its reach through a network of multispecialty hospitals spread across several states in southern and western India. KIMS has built its reputation on providing a broad spectrum of healthcare services, ranging from basic preventive care to advanced super specialty treatments. By blending cutting-edge medical technology with a team of experienced professionals, it has positioned itself as a destination for both domestic and international patients seeking reliable medical solutions. The financial engine of KIMS runs on its comprehensive service offerings, which cater to a wide range of medical needs. Revenue streams are generated primarily through inpatient and outpatient services, surgical procedures, diagnostic services, and pharmacy sales. By maintaining a focus on operational efficiency and leveraging economies of scale, KIMS has managed to offer competitive pricing, thus broadening its accessibility. Furthermore, the institution has strategically enhanced its profitability through partnerships, expansions, and an emphasis on sustainability within its operations. This approach not only strengthens its market position but also fuels its capability to reinvest in infrastructure, research, and development, aiming for continuous growth and innovation in the healthcare landscape.

KIMS Intrinsic Value
213.8 INR
Overvaluation 64%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
12.3%
=
Net Income
3.3B
/
Revenue
27.1B
What is the Net Margin of Krishna Institute of Medical Sciences Ltd?

Based on Krishna Institute of Medical Sciences Ltd's most recent financial statements, the company has Net Margin of 12.3%.